Medicare Enrolled
Dr. Alexander Selioutski, M.D.
Family Medicine · Mayville, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Selioutski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Selioutski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Selioutski
Dr. Alexander Selioutski is a family medicine specialist in Mayville, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Selioutski performed 1,976 Medicare services across 1,027 unique beneficiaries.
Between the years covered by Open Payments, Dr. Selioutski received a total of $6,439 from 57 pharmaceutical and/or device companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Selioutski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in NY
$6,439 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,976
Medicare services
Top 13% in NY for family medicine
1,027
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~99 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
258 | $11 | $25 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
253 | $80 | $106 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
222 | $76 | $130 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
143 | $40 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $55 | $91 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
137 | $139 | $183 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
106 | $34 | $50 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
98 | $60 | $128 |
| Injection, methylprednisolone acetate, 40 mg | 88 | $5 | $12 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
77 | $101 | $354 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
70 | $29 | $58 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
66 | $30 | $45 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
45 | $59 | $123 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
38 | $125 | $130 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
37 | $13 | $18 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
32 | $10 | $25 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
31 | $63 | $84 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
30 | $2 | $5 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $130 | $185 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
19 | $48 | $117 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
17 | $24 | $25 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
15 | $57 | $78 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
12 | $61 | $68 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
12 | $40 | $57 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,439
Total received (2018-2024)
Avg $920/year across 7 years
Top 9% in NY for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
383
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,439 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,070
2023
$680
2022
$1,033
2021
$603
2020
$547
2019
$1,133
2018
$1,372
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$126
ABBVIE INC.
$113
Astellas Pharma US Inc
$104
Lilly USA, LLC
$95
Sumitomo Pharma America, Inc.
$93
GlaxoSmithKline, LLC.
$72
Novo Nordisk Inc
$67
Otsuka America Pharmaceutical, Inc.
$50
Merck Sharp & Dohme LLC
$45
Lundbeck LLC
$34
AstraZeneca Pharmaceuticals LP
$32
Bayer Healthcare Pharmaceuticals Inc.
$32
Janssen Pharmaceuticals, Inc
$31
Dexcom, Inc.
$28
Phathom Pharmaceuticals, Inc.
$23
Insulet Corporation
$22
Hologic Sales and Service, LLC
$18
Collegium Pharmaceutical, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Amgen Inc.
$17
Boston Scientific Corporation
$17
SHIELD THERAPEUTICS INC
$16
Top 3 companies account for 32.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$814
GlaxoSmithKline, LLC.
$697
PFIZER INC.
$572
Lilly USA, LLC
$534
AstraZeneca Pharmaceuticals LP
$313
Amgen Inc.
$303
Boehringer Ingelheim Pharmaceuticals, Inc.
$283
Janssen Pharmaceuticals, Inc
$239
ABBVIE INC.
$229
SANOFI-AVENTIS U.S. LLC
$225
Abbott Laboratories
$130
Astellas Pharma US Inc
$125
Indivior Inc.
$120
SANOFI PASTEUR INC.
$107
Merck Sharp & Dohme Corporation
$102
Grifols USA, LLC
$97
Amarin Pharma Inc.
$96
Otsuka America Pharmaceutical, Inc.
$94
Supernus Pharmaceuticals, Inc.
$94
Kowa Pharmaceuticals America, Inc.
$94
Sumitomo Pharma America, Inc.
$93
Merck Sharp & Dohme LLC
$91
AbbVie Inc.
$85
Dexcom, Inc.
$84
Lundbeck LLC
$77
Mylan Specialty L.P.
$72
Collegium Pharmaceutical, Inc.
$49
Bayer Healthcare Pharmaceuticals Inc.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40
RedHill Biopharma Inc.
$34
Sun Pharmaceutical Industries Inc.
$24
Phathom Pharmaceuticals, Inc.
$23
Ultragenyx Pharmaceutical Inc.
$23
Insulet Corporation
$22
BioDelivery Sciences International, Inc.
$22
Ferring Pharmaceuticals Inc.
$20
Daiichi Sankyo Inc.
$19
Biohaven Pharmaceuticals, Inc.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$19
Zyla Life Sciences, Inc.
$19
Hologic Sales and Service, LLC
$18
Xeris Pharmaceuticals, Inc.
$18
Boston Scientific Corporation
$17
Eisai Inc.
$16
Gilead Sciences, Inc.
$16
SHIELD THERAPEUTICS INC
$16
Valeritas, Inc.
$15
Alkermes, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Teva Pharmaceuticals USA, Inc.
$14
Medtronic, Inc.
$14
DEXCOM, INC.
$13
Purdue Pharma L.P.
$13
Bayer HealthCare Pharmaceuticals Inc.
$13
Flexion Therapeutics, Inc.
$12
MannKind Corporation
$11
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIRSUPRA · AJOVY · ANORO · APTIMA · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BREO · BREZTRI · BUNAVAIL 2.1 mg 30-count box · CHANTIX · COLOGUARD · COMIRNATY · Crysvita · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EUFLEXXA · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GEMTESA · GLYXAMBI · GVOKE PFS · INVOKANA · InPen · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · LYRICA · Livalo · MENACTRA · MOUNJARO · MOVANTIK · Morphabond ER · Movantik · NUCALA · NURTEC ODT · Neuromodulation Dspsbls and Accs · Omnipod · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · PREVNAR 20 · Prolastin-C Liquid · QULIPTA · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SPIRIVA · SPRAVATO · SPRIX · STEGLATRO · STIOLTO RESPIMAT · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMBICORT · SYMPROIC · Saxenda · Seglentis · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TRUMENBA · Tresiba · Trintellix · UBRELVY · V-GO · VIBERZI · VOQUEZNA · Vascepa · Veozah · Victoza · Vivitrol 380 mg · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · XTAMPZA · YUPELRI · Yupelri · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for family medicine in NY.
Geographic Context
Family medicine physicians within 10 mi
76
Per 100K population
60.2
County median income
$56,507
Nearest hospital
WESTFIELD MEMORIAL HOSPITAL, INC
6.4 mi
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Selioutski is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with low-engagement industry engagement in the top 9% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Selioutski experienced with drug test with direct observation?
Based on Medicare claims data, Dr. Selioutski performed 258 drug test with direct observation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Selioutski receive payments from pharmaceutical companies?
Yes. Dr. Selioutski received a total of $6,439 from 57 companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Selioutski's costs compare to other family medicine physicians in Mayville?
Dr. Selioutski's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Selioutski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Mayville
Browse family medicine physicians in Mayville ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NY
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NY
Which NY family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology